# Síndrome da carbamazepina fetal

> Página oficial: https://raras.org/doenca/sindrome-da-carbamazepina-fetal
> Fonte: Raras.org — Banco de Dados de Doenças Raras em Português (CC BY-NC-SA 4.0)
> Última atualização: 2026-05-07

## Identificadores

- **ORPHA**: 370076 — https://www.orpha.net/en/disease/detail/370076
- **CID-10**: Q86.8

## Descrição clínica

A drug-related embryofetopathy that can occur when an embryo/fetus is exposed to carbamazepine and that is characterized by facial dysmorphism, with some similarities to that seen in fetal valproate syndrome (see this term), such as epicanthal folds, upward slanting palpebral fissures, short nose, micrognathia and malar hypoplasia, as well as nail dysplasia and major anomalies including cleft lip/palate, neural tube defects and cardiac anomalies. In utero exposure to carbamazepine, in combination with valproate, has been associated with significant developmental delay (particularly affecting verbal intelligence) and a high rate of congenital anomalies.

## Epidemiologia e herança

- **Prevalência**: Unknown
- **Padrão de herança**: Not applicable

## Importante

O Raras **não diagnostica e não prescreve**. Esta página é educativa e informativa.
Pacientes devem consultar profissionais de saúde qualificados para decisões clínicas.

---

**Citação sugerida**: Raras.org — Síndrome da carbamazepina fetal. Disponível em: https://raras.org/doenca/sindrome-da-carbamazepina-fetal
**Formato HTML**: https://raras.org/doenca/sindrome-da-carbamazepina-fetal
**Formato RDF/Turtle**: https://raras.org/api/rdf?orpha=370076